Shopping Cart
- Remove All
- Your shopping cart is currently empty
Evinacumab (REGN1500) is a humanized monoclonal antibody targeting ANGPTL3. It is useful for studying cardiovascular diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $372 | In Stock | |
5 mg | $993 | In Stock | |
10 mg | $1,330 | In Stock | |
25 mg | $1,980 | In Stock | |
50 mg | $2,680 | In Stock |
Description | Evinacumab (REGN1500) is a humanized monoclonal antibody targeting ANGPTL3. It is useful for studying cardiovascular diseases. |
In vitro | Evinacumab has similar affinity for ANGPTL3 in human, mouse, rat and monkey with KD = 0.26-1.28 nM. [1] |
In vivo | Evinacumab (10 mg/kg intrperitoneally administered once weekly for 8 weeks) reduced serum TGs in C57Bl/6 mice with normal lipemia. After Evinacumab treatment, heparin LPL activity increased 1.8 times in C57Bl/6 mice and 2.5 times in db/db mice. Evinacumab (3 mg/kg or 10 mg/kg) reduced blood lipids in cynomolgus monkeys. [1] |
Alias | REGN1500, REGN 1500 |
Molecular Weight | 145.5 kDa |
Cas No. | 1446419-85-7 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.